HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA
,
Abstract
Please provide alternate text for this image to ensure accessibility for users with text-only browsers or assistive devices.Zhao J, Qiu M, Li M, et al (2010). Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China. Rheumatol Int, 30:1565-70.
Csepregi A, Rojkovich B, Nemesanszky E, et al (2000). Chronic seropositive polyarthritis associated with hepatitis B virus-induced chronic liver disease: a sequel of virus persistence. Arthritis Rheum, 43:232-3.
Csepregi A, Nemesanszky E, Rojkovich B, Poor G (2001). Rheumatoid arthritis and hepatitis B virus: evaluating the pathogenic link. J Rheumatol, 28:474-7.
Zou CJ, Zhu LJ, Li YH, et al (2013). The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis. Clin Rheumatol, 32:787-95
| Files | ||
| Issue | Vol 46 No 8 (2017) | |
| Section | Letter to the Editor | |
| Keywords | ||
| indexing the submission separate terms | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
WANG F, LV S, CAI J, ZHOU X, ZHU Q, XU J. HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA. Iran J Public Health. 2017;46(8):1139-1140.
